Syncope, a transient loss of consciousness due to cerebral hypoperfusion, presents a diagnostic puzzle due to its multifactorial etiology. This article aims to provide a comprehensive approach to its diagnosis and management in clinical practice.
Accurate diagnosis of syncope requires a detailed history, physical examination, and selective use of diagnostic tests. History should focus on the circumstances preceding the event, presence of prodromal symptoms, and post-event recovery. Physical examination should include orthostatic blood pressure measurements and a cardiovascular examination. Electrocardiogram (ECG) is the most useful initial diagnostic test. Further testing, such as echocardiography or tilt-table testing, should be guided by clinical suspicion.
Syncope can be classified into three broad categories: reflex (neurally-mediated), orthostatic hypotension, and cardiac. Reflex syncope, the most common type, includes vasovagal, situational, and carotid sinus hypersensitivity. Orthostatic hypotension, often drug-induced, necessitates a review of the patient's medication. Cardiac syncope, the most serious type, often indicates underlying structural heart disease or arrhythmia.
Management of syncope should be tailored to the underlying cause. Reflex syncope can often be managed with patient education and lifestyle modifications. Orthostatic hypotension may necessitate medication changes. Cardiac syncope often requires specialist referral for potential interventions such as pacemaker implantation or cardiac surgery.
While syncope is generally benign, it can be a marker of serious underlying disease. Prognosis largely depends on the underlying cause, with cardiac syncope associated with a significantly worse prognosis. Regular follow-up is crucial to monitor for potential complications.
As clinicians, we are often faced with the challenge of diagnosing and managing syncope. By adopting a comprehensive approach, we can better identify the underlying cause, guide appropriate management, and improve patient outcomes.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation